Retrospective single-arm cohort study of steroid-dependent minimal change nephrotic syndrome treated with very low-dose rituximab

Conclusions regarding the best rituximab (RTX) dose to maintain remission and reduce immunosuppressant dependence in adult patients with steroid-dependent minimal change nephrotic syndrome (MCNS) are inconsistent. We report the first low-dose (< 375 mg/m BSA) RTX therapy, administered once every...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical nephrology 2021-01, Vol.95 (1), p.29-36
Hauptverfasser:	Fujimoto, Keiji, Kagaya, Yu, Kumano, Syo, Fujii, Ai, Tsuruyama, Yuko, Matsuura, Toshikazu, Yamazaki, Keita, Nomura, Kanae, Okada, Keiichiro, Okino, Kazuaki, Adachi, Hiroki, Furuichi, Kengo, Yokoyama, Hitoshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Cohort analysis Drug dosages Drug Therapy, Combination Female Glucocorticoids - therapeutic use Humans Immunosuppressive Agents - therapeutic use Immunotherapy Kidney diseases Kidney transplants Male Medical records Middle Aged Monoclonal antibodies Nephrology Nephrosis, Lipoid - drug therapy Nephrotic Syndrome - drug therapy Patients Prednisolone - therapeutic use Retrospective Studies Rituximab - therapeutic use Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!